3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Other
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Stomatitis
1
Mucositis
1
Mouth Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Exercise
15
Metformin
14
Surveys and Questionnaires
12
Radiotherapy
9
Methods
7
naloxegol
6
Nutrition Assessment
6
Counseling
6
alvimopan
5
Resistance Training
5
Psychiatric Rehabilitation
5
Exenatide
5
Early Intervention, Educational
5
Diet Therapy
5
Diet
5
Sugars
4
Mindfulness-Based Stress Reduction
4
Injections
4
Fibroblast Growth Factor 7
4
Educational Status
4
Drug Therapy
4
Vitamin D
3
Therapeutics
3
Standard of Care
3
Liraglutide
3
Interviews as Topic
3
Fentanyl
3
Cryotherapy
3
Cognitive Behavioral Therapy
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
RRx-001
×
Other
×
Clear all
NCT03515538
2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2
Completed
53 enrolled
15 charts